ACRS
Aclaris Therapeutics, Inc.Recent alerts on ACRS
All signals →
News
Aclaris Therapeutics GAAP EPS of -$0.15 beats by $0.01, revenue of $2M beats by $0.68M
26d ago
SEC filing
ACRS Reports $1.2M Revenue, $0.01 EPS, +150% YoY, Launches Phase 2b ATI-052 Asthma Trial, $200M Cash Runway Through 2028
26d ago
Insider trade
Sale by Braden Michael Leonard
35d ago
News
Aclara Sees Prospect of Fast-Tracking Rare Earth Project With Chile’s Next President
141d ago
News
Aclarion Provides 2025 Update and 2026 Corporate Outlook
145d ago
Get push alerts for ACRS
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS